12 Nov, 2024 What to Expect from Bank Regulation in the Second Trump Administration By Melissa Hall As the planning for the transition to a second Trump administration begins, so are discussions and forecasts regarding what the...
04 Nov, 2024 Online Consent to Tracking Software Under California Law: A Dive into the Shah v. Fandom Case By Christopher Ott An online advertising gold rush began from an unlikely source: meticulously mining the data beneath every click, scroll and interaction....
30 Oct, 2024 Third Circuit Confirms that An All Assets Lien Does Not Extend to Commercial Tort Claims Unless the Claim is Specifically Described By Bethany D. Simmons Noah Weingarten In re Main Street Business Funding, LLC, No. 23-2430 (3d Cir. Sept. 5, 2024) (Ambro, J.), the Third Circuit confirmed that an all-assets...
17 Oct, 2024 Is There a Useful Free-to-SVOD Model for Animation Creators? By Steve Byrd Free platforms can be a great tool for indie animators when it comes to reaching an audience. More and more animated shows are beginning...
17 Oct, 2024 FTC Releases Final Rule for Subscriptions By Robyn Mohr The FTC announced its Final Rule for subscriptions (negative options), dubbed the “click to cancel” rule because of the focus on...
16 Oct, 2024 The GoldiLocks Principle: New Ninth Circuit Decision Makes It Clear that Privacy Policies Should Neither Be Too Short or Too Long By Christopher Ott Sophisticated businesses face complex and fast-changing privacy laws. On the internet, many companies have chosen to address that...
15 Oct, 2024 CBO Pours Cold Water on Retail Pricing Impact of Legislation to Expedite Generic Drug and Biosimilar Entry By Jim Czaban The Congressional Budget Office (CBO) has just released a report that seems to cast shade on recent legislative proposals that aim to...
09 Oct, 2024 Bankruptcy Court Refuses to Grant Liens on Avoidance Claims By Noah Weingarten Bethany D. Simmons In In re BDC Group, Inc., No. 23-00484, 2024 Bankr. LEXIS 2105 (Bankr. N.D. Iowa), the Iowa bankruptcy court held that a pre-petition...
12 Sep, 2024 FDA Serves Up a Stricter Enforcement Standard for Celebrities Endorsing Rx Drugs By Jim Czaban Being a celebrity has its challenges. Adding a new one to the list, the U.S. Food and Drug Administration (FDA) has recently issued an...
26 Aug, 2024 Third Circuit Decision Provides a Cautionary Tale in Negotiating Future Payment Rights By Bethany D. Simmons Noah Weingarten In MaIlinckrodt PLC v. Sanofi-Aventis U.S. LLC, No. 23-1111, the U.S. Court of Appeals for the Third Circuit affirmed a Delaware...
22 Aug, 2024 Adieu, Fake Revie(u)w By Libby O'Neill It’s here! The Federal Trade Commission's (FTC’s) final rule banning fake reviews and testimonials, that is. Some of you may remember...
21 Aug, 2024 Allergan Holding Protects "First-Filed" Parent Patents from Their Misbehaving Patent Offspring By Jonathan B. Thielbar This month, in Allergan USA, Inc. v. MSN Laboratories Private Ltd., the Federal Circuit added to the ongoing patent-family drama...